Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer
This study has been completed.
Sponsor:
Sarah Cannon Research Institute
Collaborators:
Bristol-Myers Squibb
Eli Lilly and Company
Information provided by:
Sarah Cannon Research Institute
ClinicalTrials.gov Identifier:
NCT00193310
First received: September 12, 2005
Last updated: January 21, 2009
Last verified: January 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2009 |
| Primary Completion Date: | November 2003 (Final data collection date for primary outcome measure) |